Second-line treatment for chronic tuberculosis

Lancet. 2002 Nov 2;360(9343):1430. doi: 10.1016/S0140-6736(02)11388-2.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antitubercular Agents / therapeutic use*
  • Humans
  • Treatment Outcome
  • Tuberculosis, Multidrug-Resistant / drug therapy*

Substances

  • Antitubercular Agents